Buy or sell Visby Medical stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Visby Medical Stock
PCR-Based Medical Testing
About Visby Medical Stock
Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases. The company develops a device platform that aims to redefine the way an illness is tested and treated. They believe that by taking a human-centric, technology-first approach to device development and they can create tools that are both highly accurate and delightful to use.
Investors
Artiman Ventures
Biomedical Advanced Research and Development Authority (BARDA)
J Ventures
Plug and Play Tech Centre
Rappi, Flutterwave, Blockdaemon, FiscalNote, BigID, Onfido, Heal, Shippo, Credit Sesame, Visby Medical
Valo Ventures
Funding History
| December 2012 | $6.0M |
|---|---|
| January 2018 | $9.5M |
| April 2019 | $100M |
| February 2021 | $12.3M |
Management
Chief Executive Officer
Adam de la Zerda
Chief Financial Officer
Mark Ibison
Press
Visby Medical Makes Strategic Hires to Continue Business Development
prnewswire - Jun, 19 2021
Visby lands $12.3M for development of POC and consumer versions of combined rapid influenza/COVID-19 PCR test
bioworld - Feb, 2 2021
FDA greenlights Visby Medical's single-use, portable PCR test for COVID-19
fiercebiotech - Feb, 11 2021
Maverick Health Partners with Visby Medical to Provide and Support Rapid COVID-19 PCR Testing
businesswire - Mar, 26 2021
EquityZen Recognized As:
